1
Entacapone Combination With Imatinib for Treatment of GIST
Condition(s):Gastrointestinal Stromal Tumor, MalignantLast Updated:December 8, 2021Active, not recruiting
Entacapone: 59 Clinical Trials, Page 1 of 6
Hide Studies Not Open or Pending
2
Effect of Entacapone on Bodyweight Loss in Obese Population
Condition(s):ObesityLast Updated:February 2, 2015Unknown status
3
Pilot Study of Entacapone for Methamphetamine Abuse
Condition(s):Methamphetamine DependenceLast Updated:September 12, 2019Completed
4
COMT Polymorphism and Entacapone Efficacy
Condition(s):Parkinson’s DiseaseLast Updated:April 29, 2010Completed
5
Entacapone Augmentation for Schizophrenia
Condition(s):SchizophreniaLast Updated:August 25, 2010Completed
6
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
Condition(s):Parkinson Disease; Multiple System Atrophy; Autonomic Nervous System DiseasesLast Updated:July 17, 2014Terminated
7
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson’s Disease Patients With Early Wearing-off
Condition(s):Parkinson’s DiseaseLast Updated:March 15, 2011Completed
8
An Extension Study of Entacapone in Patients With Parkinson’s Disease With End-of-dose Wearing-off. This Study is Not Recruiting in the United States
Condition(s):Parkinson’s DiseaseLast Updated:February 23, 2017Completed
9
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson’s Disease and Demonstrating Non-motor Symptoms of Wearing Off
Condition(s):Parkinson’s DiseaseLast Updated:February 18, 2011Terminated
10
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson’s Disease
Condition(s):Parkinson’s Disease With End of Dose Wearing OffLast Updated:March 30, 2017Completed